PCRBIO Research Grant

The PCRBIO Research Grant is an initiative by PCR Biosystems, a company recognized for its extensive suite of reagents and molecular biology tools, including qPCR, PCR, cDNA synthesis, and NGS applications. Known for its scientific rigor and customer-centric approach, PCR Biosystems aims to support researchers working across multiple domains of biological science. This grant serves to expand access to PCR reagents by directly funding research that relies heavily on polymerase chain reaction technologies, particularly in human health, microbiology, environmental sustainability, plant sciences, and any other biology-centric disciplines. The purpose of the PCRBIO Research Grant is to alleviate resource constraints for academic researchers in the United States by providing $10,000 worth of PCR reagents. This support is structured to benefit a broad academic audience, with the main awardee receiving $6,000 in reagents distributed over a three-year period, and four additional recipients each awarded $1,000 in reagents. The grant also includes access to technical assistance for optimizing the use of PCR Biosystems’ products. The support is not monetary but in the form of reagent supply, targeting labs that conduct frequent PCR testing. Eligibility is limited to full-time academic researchers at U.S.-based institutions, inclusive of PhD candidates, postdoctoral researchers, lab managers, and principal investigators. The program encourages consolidated applications from lab groups rather than multiple entries from the same team. This ensures more cohesive submissions and promotes collaborative research efforts. The judging criteria will focus on expected scientific impact, broader health or societal relevance, innovation, clarity, completeness, and realistic use of reagents. Applications open in September and close on November 30, 2025. Awards are announced and funding begins in January 2026. Although specific reviewers have yet to be announced, the grantor expects the review process to be rigorous. There is no pre-application phase; the only requirement is submission through the provided form on the grant website. This simplicity makes the grant accessible, especially for early-career researchers. The grant is recurring annually, indicating that future cycles are likely to follow similar timelines, with application windows beginning each September and closing at the end of November. Contact information is clearly provided for both the UK and U.S. offices of PCR Biosystems, with U.S. applicants directed to the Pennsylvania office for correspondence. There are no mentions of cost-sharing or matching fund requirements, making this a straightforward opportunity for eligible academic researchers.

Focus on clear rationale for reagent needs and research impact; consolidate team applications for stronger entries.